Evogene files for proposed IPO in US

Date:09-25-2013

Evogene Ltd. (EVGN) recently announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed public offering of its ordinary shares in the United States. The size of the offering has not yet been finalized. Evogene has applied to have its ordinary shares listed on the New York Stock Exchange under the ticker symbol “EVGN.”

Credit Suisse Securities and Deutsche Bank Securities are the joint book-running managers for the proposed offering, and Oppenheimer & Co. and Piper Jaffray & Co. are the co-managers.

A registration statement relating to these securities has been filed with the United States Securities and Exchange Commission (SEC) but has not yet become effective.